{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:46:41Z","timestamp":1761598001657},"reference-count":39,"publisher":"Bentham Science Publishers Ltd.","issue":"3","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2019,2,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Humanin is a novel neuronal peptide that has displayed potential in the treatment\nof Alzheimer\u2019s Disease through the suppression of inflammatory IL-6 cytokine receptors. Such\nreceptors are found throughout the body, including the eye, suggesting its other potential applications.\nAge-related Macular Degeneration (AMD) is the leading cause of blindness in the developing world.\nThere is no cure for this disease, and current treatments have several negative side effects associated\nwith them, making finding other treatment options desirable.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p> In this study, the potential applications in treating AMD for a more potent humanin derivative,\nAGA-HNG, were studied.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods: <\/jats:title>\n<jats:p>AGA-HNG was synthesized and encapsulated in chitosan Nanoparticles (NPs), which were\nthen characterized for their size, Encapsulation Efficiency (EE), and drug release. Their ability to suppress\nVEGF secretion and protect against oxidative apoptosis was studied in vitro using ARPE-19 cells.\nThe chitosan NPs exhibited similar anti-VEGF properties and oxidative protection as the free protein\nwhile exhibiting superior pharmaceutical characteristics including biocompatibility and drug release.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results: <\/jats:title>\n<jats:p>Drug-loaded NPs exhibited a radius of 346nm with desirable pharmacokinetic properties including\na stable surface charge (19.5 \u00b1 3.7 mV) and steady drug release capacity. AGA-HNG showed\ngreat promise in mediating apoptosis in hypoxic cells. They were also able to significantly reduce\nVEGF expression in vitro with reduced cellular toxicity compared to the free drug.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion: <\/jats:title>\n<jats:p>The ability of this drug delivery system to reduce retinal apoptosis with desirable pharmacokinetic\nand biocompatible properties makes this a promising therapeutic option for AMD.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1567201815666181031163111","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T07:53:13Z","timestamp":1541058793000},"page":"226-232","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Humanin Nanoparticles for Reducing Pathological Factors Characteristic of Age-Related Macular Degeneration"],"prefix":"10.2174","volume":"16","author":[{"given":"Aum","family":"Solanki","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, USF College of Pharmacy, University of South Florida, Tampa, FL 33647, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudy","family":"Smalling","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, USF College of Pharmacy, University of South Florida, Tampa, FL 33647, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham H.","family":"Parola","sequence":"additional","affiliation":[{"name":"Department of Chemistry, The Faculty of Natural Sciences, Ben-Gurion University of the Negev, Beersheba, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilana","family":"Nathan","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry and Pharmacology, The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beersheba, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roni","family":"Kasher","sequence":"additional","affiliation":[{"name":"Department of Desalination and Water Treatment, Zuckerberg Institute for Water Research, The Blaustein Institutes for Desert Research, Ben-Gurion University of the Negev, Sede-Boquer Campus, Beersheba, 8499000, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashwant","family":"Pathak","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, USF College of Pharmacy, University of South Florida, Tampa, FL 33647, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijaykumar","family":"Sutariya","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, USF College of Pharmacy, University of South Florida, Tampa, FL 33647, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.7.1019","volume":"122","author":"Friedman D.S.","year":"2004","unstructured":"Friedman DS, O\u2019Colmain BJ, Mu\u00f1oz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J.  Prevalence of age-related macular degeneration in the United States.","journal-title":"Arch Ophthalmol"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0161-6420(95)31034-2","volume":"102","author":"Vingerling J.R.","year":"1995","unstructured":"Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, de Jong PT.  The prevalence of age-related maculopathy in the Rotterdam study.","journal-title":"Ophthalmology"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1056\/NEJMra0801537","volume":"358","author":"Jager R.D.","year":"2008","unstructured":"Jager RD, Mieler WF, Miller JW.  Age-related macular degeneration.","journal-title":"N Engl J Med"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"2913612","DOI":"10.1155\/2016\/2913612","volume":"2016","author":"Al Gwairi O.","year":"2016","unstructured":"Al Gwairi O, Thach L, Zheng W, Osman N, Little PJ.  Cellular and molecular pathology of age-related macular degeneration: Potential role for proteoglycans.","journal-title":"J Ophthalmol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","volume":"29","author":"Nickla D.L.","year":"2010","unstructured":"Nickla DL, Wallman J.  The multifunctional choroid.","journal-title":"Prog Retin Eye Res"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jamaophthalmol.2013.5799","volume":"132","author":"Bird A.C.","year":"2014","unstructured":"Bird AC, Phillips RL, Hageman GS.  Geographic atrophy: A histopathological assessment.","journal-title":"JAMA Ophthalmol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.mam.2012.04.006","volume":"33","author":"Mettu P.S.","year":"2012","unstructured":"Mettu PS.  Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration.","journal-title":"Mol Aspects Med"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"510285","DOI":"10.1155\/2014\/510285","volume":"2014","author":"Fernandez-Robredo P.","year":"2014","unstructured":"Fernandez-Robredo P, Sancho A, Johnen S, Recalde S, Gama N, Thumann G, Groll J, Garc\u00eda-Layana A.  Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering.","journal-title":"J Ophthalmol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5114\/ceji.2016.63132","volume":"41","author":"Po\u017carowska D.","year":"2016","unstructured":"Po\u017carowska D, Po\u017carowski P.  The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy.","journal-title":"Cent Eur J Immunol"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1038\/srep08627","volume":"5","author":"Vakalis N.","year":"2015","unstructured":"Vakalis N, Echiadis G, Pervena A, Deligiannis I, Kavalarakis E, Giannikakis S, Papaefthymiou I.  Intravitreal combination of dexamethasone sodium phosphate and bevacizumab in the treatment of exudative AMD.","journal-title":"Sci Rep"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.survophthal.2007.12.005","volume":"53","author":"Cunningham M.A.","year":"2008","unstructured":"Cunningham MA, Edelman JL, Kaushal S.  Intravitreal steroids for macular edema: the past, the present, and the future.","journal-title":"Surv Ophthalmol"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1442-9071.2001.00360.x","volume":"29","author":"Young S.","year":"2001","unstructured":"Young S, Larkin G, Branley M, Lightman S.  Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis.","journal-title":"Clin Exp Ophthalmol"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/archopht.1974.01010010155016","volume":"92","author":"Graham R.O.","year":"1974","unstructured":"Graham RO, Peyman GA.  Intravitreal injection of dexamethasone: Treatment of experimentally induced endophthalmitis.","journal-title":"Arch Ophthalmol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.optm.2005.06.013","volume":"76","author":"Reichle M.L.","year":"2005","unstructured":"Reichle ML.  Complications of intravitreal steroid injections.","journal-title":"Optometry"},{"key":"ref=15","first-page":"1091","volume":"40","author":"Offord E.A.","year":"1999","unstructured":"Offord EA, Sharif NA, Mac\u00e9 K, Tromvoukis Y, Spillare EA, Avanti O, Howe WE, Pfeifer AM.  Immortalized human corneal epithelial cells for ocular toxicity and inflammation studies.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0039-6257(93)90141-S","volume":"37","author":"Urtti A.","year":"1993","unstructured":"Urtti A, Salminen L.  Minimizing systemic absorption of topically administered ophthalmic drugs.","journal-title":"Surv Ophthalmol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14712598.3.1.45","volume":"3","author":"Duvvuri S.","year":"2003","unstructured":"Duvvuri S, Majumdar S, Mitra AK.  Drug delivery to the retina: Challenges and opportunities.","journal-title":"Expert Opin Biol Ther"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.biopha.2018.08.138","volume":"107","author":"Nayak K.","year":"2018","unstructured":"Nayak K, Misra M.  A review on recent drug delivery systems for posterior segment of eye.","journal-title":"Biomed Pharmacother"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2017.07.002","volume":"128","author":"Kaji H.","year":"2018","unstructured":"Kaji H, Nagai N, Nishizawa M, Abe T.  Drug delivery devices for retinal diseases.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"e1473","DOI":"10.1002\/wnan.1473","volume":"10","author":"Bisht R.","year":"2018","unstructured":"Bisht R, Mandal A, Jaiswal JK, Rupenthal ID.  Nanocarrier mediated retinal drug delivery: Overcoming ocular barriers to treat posterior eye diseases.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1246\/bcsj.20170377","volume":"91","author":"Bhattacharyya K.","year":"2017","unstructured":"Bhattacharyya K, Mukherjee S.  Fluorescent metal nano-clusters as next generation fluorescent probes for cell imaging and drug delivery.","journal-title":"Bull Chem Soc Jpn"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1246\/bcsj.20170156","volume":"90","author":"Komiyama M.","year":"2017","unstructured":"Komiyama M, Yoshimoto K, Sisido M, Ariga K.  Chemistry can make strict and fuzzy controls for bio-systems: DNA nanoarchitectonics and cell-macromolecular nanoarchitectonics.","journal-title":"Bull Chem Soc Jpn"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/10837450.2014.965326","volume":"21","author":"Hirani A.","year":"2016","unstructured":"Hirani A, Grover A, Lee YW, Pathak Y, Sutariya V.  Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration.","journal-title":"Pharm Dev Technol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1208\/s12249-014-0165-0","volume":"15","author":"Grover A.","year":"2014","unstructured":"Grover A, Hirani A, Pathak Y, Sutariya V.  Brain-targeted delivery of docetaxel by glutathione-coated nanoparticles for brain cancer.","journal-title":"AAPS PharmSciTech"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.arr.2015.09.002","volume":"24","author":"Hanus J.","year":"2015","unstructured":"Hanus J, Anderson C, Wang S.  RPE necroptosis in response to oxidative stress and in AMD.","journal-title":"Ageing Res Rev"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"e2526","DOI":"10.1038\/cddis.2016.437","volume":"8","author":"Jang K-H.","year":"2017","unstructured":"Jang K-H, Do YJ, Son D, Son E, Choi JS, Kim E.  AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration.","journal-title":"Cell Death Dis"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1167\/iovs.14-14238","volume":"55","author":"Matsumoto H.","year":"2014","unstructured":"Matsumoto H, Kataoka K, Tsoka P, Connor KM, Miller JW, Vavvas DG.  Strain difference in photoreceptor cell death after retinal detachment in mice.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1134\/S2079057017010155","volume":"7","author":"Telegina D.","year":"2017","unstructured":"Telegina D, Kozhevnikova O, Kolosova N.  Molecular mechanisms of cell death in retina during development of age-related macular degeneration.","journal-title":"Adv Gerontol"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/1755-5922.12168","volume":"34","author":"Charununtakorn S.T.","year":"2016","unstructured":"Charununtakorn ST, Shinlapawittayatorn K, Chattipakorn SC, Chattipakorn N.  Potential roles of humanin on apoptosis in the heart.","journal-title":"Cardiovasc Ther"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2119\/molmed.2015.00073","volume":"21","author":"Cohen A.","year":"2015","unstructured":"Cohen A, Lerner-Yardeni J, Meridor D, Kasher R, Nathan I, Parola AH.  Humanin derivatives inhibit necrotic cell death in neurons.","journal-title":"Mol Med"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijbiomac.2016.04.070","volume":"89","author":"Kalam M.A.","year":"2016","unstructured":"Kalam MA.  Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.","journal-title":"Int J Biol Macromol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IJN.S150319","volume":"13","author":"Yu K.","year":"2018","unstructured":"Yu K, Wang Y, Wan T, Zhai Y, Cao S, Ruan W, Wu C, Xu Y.  Tacrolimus nanoparticles based on chitosan combined with nicotinamide: Enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose.","journal-title":"Int J Nanomedicine"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"E323","DOI":"10.1208\/pt060242","volume":"6","author":"D\u2019Souza S.S.","year":"2005","unstructured":"D\u2019Souza SS, DeLuca PP.  Development of a dialysis  release method for biodegradable microspheres.","journal-title":"AAPS PharmSciTech"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/CBM-170444","volume":"21","author":"Duan S.","year":"2018","unstructured":"Duan S.  Silencing the autophagy-specific gene Beclin-1 contributes to attenuated hypoxia-induced vasculogenic mimicry formation in glioma.","journal-title":"Cancer Biomark"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/ma10080929","volume":"10","author":"Raveendran S.","year":"2017","unstructured":"Raveendran S, Rochani AK, Maekawa T, Kumar DS.  Smart carriers and nanohealers: A nanomedical insight on natural polymers.","journal-title":"Materials"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.2147\/IJN.S146516","volume":"12","author":"Ahmadi F.","year":"2017","unstructured":"Ahmadi F, Ghasemi-Kasman M, Ghasemi S, Tabari MG, Pourbagher R, Kazemi S, Alinejad-Mir A.  Induction of apoptosis in HeLa cancer cells by an ultrasonic-mediated synthesis of curcumin-loaded chitosan\u2013alginate\u2013STPP nanoparticles.","journal-title":"Int J Nanomedicine"},{"key":"ref=37","first-page":"20","volume":"11","author":"Cheng L.","year":"2017","unstructured":"Cheng L, Yu H, Yan N, Lai K, Xiang M.  Hypoxia-inducible factor-1\u03b1 target genes contribute to retinal neuroprotection.","journal-title":"Front Cell Neurosci"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"1675230","DOI":"10.1155\/2017\/1675230","volume":"2017","author":"Minasyan L.","year":"2017","unstructured":"Minasyan L, Sreekumar PG, Hinton DR, Kannan R.  Protective mechanisms of the mitochondrial-derived peptide humanin in oxidative and endoplasmic reticulum stress in RPE cells.","journal-title":"Oxid Med Cell Longev"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1167\/iovs.15-17053","volume":"57","author":"Sreekumar P.G.","year":"2016","unstructured":"Sreekumar PG, Ishikawa K, Spee C, Mehta HH, Wan J, Yen K, Cohen P, Kannan R, Hinton DR.  The mitochondrial-derived peptide humanin protects RPE cells from oxidative stress, senescence, and mitochondrial dysfunctionhumanin protects RPE cells from oxidative stress.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/166858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T05:57:54Z","timestamp":1557986274000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/166858\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,2,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201815666181031163111","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-05-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}